Results 221 to 230 of about 159,806 (339)

Dental extraction in patients receiving dual antiplatelet therapy

, 2015
Paulino Sánchez-Palomino, P. Sanchez-Cobo, Alberto Rodríguez-Archilla, Maximino González‐Jaranay, Gerardo Moreu, José Luís Calvo‐Guirado, Miguel Peñarrocha Diago, Gerardo Gómez Moreno   +7 more
openalex   +1 more source

Hemocompatibility Outcomes After Aspirin Withdrawal in Long‐Term HeartMate 3 Left Ventricular Assist Device Patients on Vitamin K Antagonists

Artificial Organs, EarlyView.
Aspirin discontinuation in long‐term, stable Heart Mate 3 LVAD patients maintained on Vitamin K antagonists did not increase hemocompatibility‐related adverse events. These findings support the safety of simplified antithrombotic therapy and extend randomized evidence for aspirin avoidance to the long‐term management of Heart Mate 3 recipients ...
Melanie Arnreiter, Barbara Karner, Hebe Al Asadi, Christina Abd El‐Malak, Christiane Marko, Daniel Zimpfer, Julia Riebandt, Roxana Moayedifar, Thomas Schlöglhofer   +8 more
wiley   +1 more source

Upper Gastrointestinal Bleeding in Patients Receiving Dual Antiplatelet Therapy after Coronary Stenting

, 2009
Hiroshi Yasuda, Masaya Yamada, Susumu S. Sawada, Yutaka Endo, Kazuaki Inoue, Fuyuki Asano, Youichi Takeyama, Makoto Yoshiba   +7 more
openalex   +2 more sources

The effect of antiplatelet therapy on the incidence of carotid plaque hemorrhage. [PDF]

, 1986
Ronald L. Ernst, Alex D. Ammar, Joe J. Lin, Henry Travers   +3 more
openalex   +1 more source

Percutaneous Versus Surgical Cannulation for Femoro‐Femoral Venoarterial Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study on Cannulation‐Related Complications

Artificial Organs, EarlyView.
Percutaneous femoro‐femoral V‐A ECMO cannulation was associated with more than a two‐fold lower risk of site bleeding and nearly a six‐fold lower risk of infection compared with surgical cut‐down, with no difference in limb ischemia. Absence of distal perfusion catheterization and larger arterial cannula size were additional modifiable ischemia risk ...
Axel Dimberg, Magnus Dalén, Anders Franco‐Cereceda, Thomas Fux   +3 more
wiley   +1 more source

Who is at risk to develop late drug-eluting stent thrombosis while on dual antiplatelet therapy? A subset analysis from the Drug Eluting Stent Event Registry of Thrombosis (DESERT) [PDF]

, 2013
Ron Waksman, Rebecca Torguson, K. Kaneshige, Ajay J. Kirtane, Thomas Ryan, Richard L. Applegate, Sergio Waxman, David J. Cohen, Paul Gordon   +8 more
openalex   +1 more source

The incidence of serious complications after selective laser trabeculoplasty

Acta Ophthalmologica, EarlyView.
Abstract Purpose To evaluate the incidence of serious complications after selective laser trabeculoplasty (SLT). Methods All patients who underwent SLT at the Department of Ophthalmology, Helsinki University Hospital, were eligible for the study from 1 January 2012 to 31 December 2018.
Eeva S. Ojanen, Joni A. Turunen, Mika Harju   +2 more
wiley   +1 more source

The PREVAIL trial and low-molecular-weight heparin for prevention of venous thromboembolism [PDF]

, 2008
Muir, K.W.
core   +1 more source

The role of antiplatelet agents in stroke prevention

, 2008
M.N. Cattaneo
openalex   +1 more source

Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity [PDF]

, 1996
JW Semple, YP Milev, Donna Cosgrave, Meera Mody, Adriana Hornstein, Victor S. Blanchette, John Freedman   +6 more
openalex   +1 more source